In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a NLozol, Arifon, Fludex, Noranat, Veroxil, Tertensif, Indapamide Drug Master File in Korea (NLozol, Arifon, Fludex, Noranat, Veroxil, Tertensif, Indapamide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of NLozol, Arifon, Fludex, Noranat, Veroxil, Tertensif, Indapamide. The MFDS reviews the NLozol, Arifon, Fludex, Noranat, Veroxil, Tertensif, Indapamide KDMF as part of the drug registration process and uses the information provided in the NLozol, Arifon, Fludex, Noranat, Veroxil, Tertensif, Indapamide KDMF to evaluate the safety and efficacy of the drug.
After submitting a NLozol, Arifon, Fludex, Noranat, Veroxil, Tertensif, Indapamide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their NLozol, Arifon, Fludex, Noranat, Veroxil, Tertensif, Indapamide API can apply through the Korea Drug Master File (KDMF).
click here to find a list of NLozol, Arifon, Fludex, Noranat, Veroxil, Tertensif, Indapamide suppliers with KDMF on PharmaCompass.